UiPath stock forecast for 2026 explores PATH stock price trends, earnings, technical analysis, and analyst ratings. Is UiPath stock a buy now amid agentic AI growth? Get balanced insights on PATH stock valuation and outlook

Introduction

UiPath builds software for robotic process automation. It helps companies automate repetitive tasks using AI agents. PATH stock draws attention due to rising AI demand in enterprise automation. Broader market conditions favor tech stocks as interest rates stabilize, boosting growth names like PATH.

Investors watch UiPath stock closely after strong Q3 fiscal 2026 results. Agentic AI adoption drives larger deals and margins. PATH stock price reflects optimism in automation amid economic recovery.​

Latest Stock Price & Trend

As of the last market close on March 13, 2026, UiPath stock price stands at $14.25. The stock rose 2.1% in the past day on high volume. Over five days, PATH stock gained 4.5%, showing short-term momentum.​

In the last month, UiPath stock price climbed 8.2%, beating the Nasdaq. Three-month trend shows a 51% surge, fueled by AI news. Six-month performance added 32%, while year-to-date PATH stock is up 22%. The 52-week high hit $24.30, low at $10.40. Overall trend stays bullish, signaling investor confidence in UiPath earnings growth. This suggests accumulation potential for patient holders.

Technical Analysis

Support levels sit at $13.50 and $12.80, where buyers stepped in recently. These floors matter as they show where demand may rebound PATH stock price. Resistance looms at $15.20 and $16.50, testing seller strength.​

RSI reading at 62 indicates neutral momentum, not overbought. Values above 70 signal sell risks; below 30 means oversold buys. MACD trend shows bullish crossover, hinting at upward drive.​

The 50-day moving average at $13.90 crosses above the 200-day at $13.20, forming a golden cross. This classic bull signal predicts rallies. Trading volume trends up 15% weekly, confirming conviction behind UiPath technical analysis.​

Analyst Ratings & Price Targets

Of 25 analysts, 12 rate Buy, 10 Hold, 3 Sell. Average price target hits $16.80, with high at $22.50 and low $12.00. Recent upgrades from five firms lifted fiscal 2026 estimates 3.1%.​

Wall Street sees mid-term positivity on UiPath forecast. No downgrades in 30 days signal steady sentiment. For investors, this implies measured upside if execution holds.​

Insider Activity

Insiders bought 45,000 shares last quarter at $13.20 average. No major selling occurred. CEO Daniel Dines added 20,000 shares, showing confidence.​

Trends point to net buying, with management holding steady. Large transactions remain small versus float. This activity suggests insiders back UiPath stock long-term, easing caution flags.​

Valuation Analysis

Trailing P/E stands at 45.2, forward P/E at 32.1. Price-to-sales ratio is 5.8 amid 16% YoY revenue growth. EPS grew 12% last year.​

Free cash flow reached $120 million in Q3. Cash position hit $1.52 billion, debt low at $50 million. Compared to Zoom (P/E 28) or Microsoft (P/E 35), PATH stock appears fairly valued for growth peers. Strong liquidity supports expansion without dilution risks.​

Recent Earnings & Catalysts

Q3 fiscal 2026 revenue hit $411 million, up 16% YoY, beating estimates. EPS came in at $0.12 versus $0.10 expected. ARR grew to $1.782 billion, up 11%.​

Guidance calls for Q4 revenue near $430 million. Catalysts include peak.ai acquisition and $500 million buyback. Earnings beat sparked a 10% PATH stock rally post-report.

Bullish Case

Agentic AI scales deals 20% larger, lifting ARR retention to 107%. Market demand surges in finance, healthcare. Tech edges competitors via low-code tools.

Operational gains cut costs 8%, boosting margins to 25%. $1 billion buyback signals self-confidence in UiPath revenue growth.

Bearish Case

Competition from Microsoft Copilot pressures market share. Growth slowed from 20% peaks. Margin squeezes hit if macro weakens.

Customer churn risks rise in economic dips. Regulatory scrutiny on AI adds hurdles.

Market Sentiment & Investor Psychology

Short interest sits at 4.2% of float, down 10%. Calls outpace puts 1.5:1 in options flow. Institutions own 78%, up 2% quarterly.​

Retail piles in on AI hype via forums. Momentum favors bulls, but value checks pullback risks. Sentiment leans optimistic on UiPath stock.

Short-Term Outlook

Technicals favor gains toward $15.50 resistance. Volume supports upside if Nasdaq holds. Watch Q4 earnings March 11 for volatility.

Momentum points to 5-10% moves, but macro news could stall. Expect choppy trading next weeks.​

Medium to Long-Term Outlook

UiPath business model thrives on recurring ARR. Industry grows 25% annually via AI shift. Competitive moat builds on 10,000+ customers.​

Financial health shines with profitability. Long-term investors should hold or accumulate on dips, eyeing 20-30% growth through 2027.

FAQ

Is UiPath stock a buy right now?
Yes for growth seekers at current levels, but wait for pullbacks near support. Analysts lean Buy.​

What is the price target for UiPath stock?
Average $16.80, ranging $12-$22.50 based on earnings trajectory.​

What are major risks for UiPath stock?
Competition, slowing ARR, macro slowdowns top concerns.​

UiPath earnings outlook?
Q4 expected at $430M revenue; fiscal 2026 EPS up 3%.​

UiPath technical analysis summary?
Bullish MACD, golden cross; RSI neutral.​

Suggestion

Compare with Opendoor stock analysis.
See our Microsoft stock forecast.
Read tech sector valuation trends.

Conclusion

Hold UiPath stock for now. Bullish trends and earnings support upside, balanced by competition risks. PATH forecast favors accumulators eyeing AI growth.

Disclaimer: This article is for informational purposes only and not financial advice.